CIK 0001401667 · Accelerated filer<br>Smaller reporting company
PUMA BIOTECHNOLOGY, INC.
Sign in to watch- Ticker
- PBYI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770683487
- Phone
- (424) 248-6500
- Business address
- 10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES, CA
- Former names
- INNOVATIVE ACQUISITIONS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $612,494
- in 2 filings, $612K under 10b5-1 plans
Net −$612,494. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-13 | MILLER MICHAEL PATRICK Director | Grant or award 10b5-1 | +27,000 | 68,358 | ||
| 2023-06-13 | Cesano Alessandra Director | Grant or award | +27,000 | 27,000 | ||
| 2023-06-02 | Wong Alvin F Chief Scientific Officer | Sale 10b5-1 | −269 | $3.45 | $928 | 112,885 |
| 2023-02-10 | Wong Alvin F Chief Scientific Officer | Grant or award | +58,601 | 113,154 | ||
| 2023-02-10 | Wong Alvin F Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +81,399 | 81,399 | ||
| 2023-02-10 | NOUGUES MAXIMO F Chief Financial Officer | Grant or award | +58,601 | 159,028 | ||
| 2023-02-10 | NOUGUES MAXIMO F Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +81,399 | 81,399 | ||
| 2023-02-10 | Ludwig Jeffrey Jerome Chief Commercial Officer | Grant or award | +66,972 | 125,029 | ||
| 2023-02-10 | Ludwig Jeffrey Jerome Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +93,028 | 93,028 | ||
| 2023-02-10 | HUNT DOUGLAS M See Remarks | Grant or award | +48,136 | 119,486 | ||
| 2023-02-10 | HUNT DOUGLAS M See Remarks | Grant or award · Stock Option (Right to Buy) | +66,864 | 66,864 | ||
| 2023-02-10 | AUERBACH ALAN H President and CEO | Grant or award | +186,403 | 7,039,041 | ||
| 2023-02-10 | AUERBACH ALAN H President and CEO | Grant or award · Stock Option (Right to Buy) | +258,924 | 258,924 | ||
| 2023-01-03 | Wong Alvin F Chief Scientific Officer | Sale | −3,460 | $4.18 | $14K | 54,553 |
| 2023-01-03 | NOUGUES MAXIMO F Chief Financial Officer | Sale | −10,499 | $4.18 | $44K | 100,427 |
| 2023-01-03 | Ludwig Jeffrey Jerome Chief Commercial Officer | Sale | −6,568 | $4.18 | $27K | 58,057 |
| 2023-01-03 | HUNT DOUGLAS M See Remarks | Sale | −4,225 | $4.18 | $18K | 71,350 |
Page 7 of 7 · 137 trades